2017.,Global Tuberculosis Report -
ArditoF,PosteraroB,SanguinettiM,ZanettiS,FaddaG, 2001.Evaluation of BACTEC mycobacteria growth indicator tube (MGIT 960) automated system for drug susceptibility testing of mycobacterium tuberculosis,J Clin Microbiol 39 4440 -4
AzizMA,WrightA,LaszloA,De MuynckA,PortaelsF,Van DeunA, 2006.Epidemiology of anti-tuberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis,Lancet 368 2142 -54
WoodsG,LinS,DesmondE.,PfallerM, 2015.Susceptibility test methods: Mycobacteria, nocardia,Manual of Clinical Microbiology 1 1356 -
NoorKM,ShephardL,BastianI., 2015.Molecular diagnosis for tuberculosis,Pathology 47 250 -6
CatanzaroA,RodwellTC,CatanzaroDG,GarfeinRS,JacksonRL,SeifertM, 2015.Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis,PLoS One 10 e0136861 -
KohWJ,KoY,KimCK,LuoX,ChenJ,TangL, 2012.Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system,Ann Lab Med 32 264 -9
SaidHM,KockMM,IsmailNA,BabaK,OmarSV,OsmanAG, 2012.Comparison between the Bactec MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa,BMC Infect Dis 12 369 -
O'Grady,J , Maeurer,M , Mwaba,P , Kapata,N , Bates,M , Hoelscher,M, 2011.New and improved diagnostic for detection of drug-resistant pulmonary tuberculosis,Curr Opin Pulm Med 17 134 -41
SiddiqiS,AhmedA,AsifS,BeheraD,JavaidM,JaniJ, 2012.Direct drug susceptibility testing of mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study,J Clin Microbiol 50 435 -40
KentPT,KubicaGP, 1985.Public health microbiology: A guide for the level III laboratory. Centers for Disease Control and Prevention, Division of Laboratory Training and Consultation, -
SiddiqiSH,Rusch-GerdesS. MGIT, 2006.procedure manual,Foundation for Innovative New Diagnostics (FIND) -
1998.Laboratory series in tuberculosis control. Part II, microscopy, -
ZhangT,LVCF,WangJ,ZhengWB,LuLZ,LiuSJ, 2016.Direct tuberculosis drug susceptibility testing: time-saving and costeffective in detecting MDR-TB,Int J Tuberc Lung Dis 20 323 -8
DemersAM,VentersA,FriendrichSO,Rojas-PonceG,MapambaD,JugheliL, 2016.Direct susceptibility testing of mycobacterium tuberculosis for pyrazinamide by use of the Bactec MGIT 960 System,J Clinic Microbiol 54 1276 -81
Geneva, 2011.Non-commercial culture and drug susceptibility testing methods for screening of patients at risk of multidrug-resistant tuberculosis: policy statement, -
LawnS D,MwabaP,BatesM., 2013.Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test,Lancet Infect Dis 13 349 -61
MartinA,ImperialeB,RavolonandrianaP,CobanAY,AkgunesA,IkramA, 2014.Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drugresistant tuberculosis,J Antimicrob Chemother 69 441 -4
SattiL,IkramA,AbbasiS,MalikN,MirzaIA,MartinA, 2010.Evaluation of thin-layer agar 7H11 for the isolation of mycobacterium tuberculosis complex,Int J Tuberc Lung Dis 14 1354 -6
MooreDA,EvansCA,GilmanRH,CaviedesL,CoronelJ,VivarA, 2006.Microscopic-observation drug-susceptibility assay for the diagnosis of TB,N Engl J Med 355 1539 -50